Wednesday, August 24, 2016

You Do The Math

Here's what we're talking about with big pharma and their foot soldiers.

A one-year-old boy was prescribed antidepressants by Britain’s National Health Service (NHS), it has emerged.
NHS Tayside in Dundee, Scotland, prescribed the medication to the child in 2014, according to figures obtained by the Dundee Evening Telegraph.
The Trust prescribed anti-depressants to 450 children over a five-month period between January and May this year.
Figures reveal the most common age group to be given antidepressants were children aged between 14 and 17 and that girls are more likely to be prescribed the drug than boys.
Although very young children are sometimes prescribed antidepressants for problems including bed-wetting and chronic pain, NHS guidelines state that under 18s should not be given the drug.
Antidepressants are a type of medication used to treat clinical depression, or prevent it from recurring. However, they can also be used to treat a wide range of medical conditions, such as chronic pain and anxiety disorders,” a spokesperson for NHS Tayside said.
If appropriate for individual patients, antidepressants are prescribed and often used in combination with therapy to treat more severe depression, or other mental health conditions caused by emotional distress.
There's not a dollar big pharma doesn't covet. Couple the above with this story.


The pharmaceutical company that distributes the EpiPen is also a Clinton Foundation donor.
Hillary Clinton criticized the company, Mylan, on Wednesday, calling its price hikes of the life-saving medical device “outrageous.”
“It’s just the latest troubling example of a company taking advantage of its consumers,” said Clinton.
But those remarks highlight Clinton’s radio silence on the price of the EpiPen, which has grown steadily since 2007, when Mylan acquired rights to sell the 50-year-old drug.
EpiPen injections, which help stop potentially fatal allergic reactions, cost $57 in 2007. They now run $609. According to CNBC, the price of EpiPens has increased at a steady rate in those nine years.
As of May 2011, the price was $165. That rose to $350 in 2014 and $461 last year. You cm due the math on these numbers. Inflation is like everything else; it depends on who is paying it.

Read more: dailycaller.com/2016/08/24/company-gouging-price-of-epipens-is-a-clinton-foundation-donor-and-partner

No comments: